The multiple advantages offered by minimally invasive surgeries (MIS) is supporting their use across an expanding number of surgical procedures. This, in turn, is boosting the uptake of related devices. The widening acceptance of technologically advanced minimally invasive surgical products, coupled with initiatives by market participants to train physicians about the use of such sophisticated offerings, is also opening up new channels for revenue growth.
New analysis from Frost & Sullivan (medicaldevices.frost.com), European Markets for Minimally Invasive Surgical Devices, finds that the market earned revenues of $378.8 million in 2006 and estimates this to reach $532.1 million in 2013.
If you are interested in a virtual brochure, which provides manufacturers, end users and other industry participants with an overview of the latest analysis of the European Markets for Minimally Invasive Surgical Devices, send an email to Radhika Menon Theodore, Corporate Communications, at rmtheodore[.]frost.com with your full name, company name, title, telephone number, email address, city, state and country. We will send you the information through email upon receipt of the above information.
MIS reduce the duration of hospital stays and, since the incision is small and blood loss is minimal. Accordingly, the acceptance of MIS is rising, since they offer faster recovery rates compared to open surgical procedures. This trend is boosting revenue prospects.
“Minimally invasive surgeries are increasingly being preferred over more traditional, open surgical procedures,” says Frost & Sullivan Research Analyst Kezia Jasper. “This trend is encouraging the revenue growth of the endoscopes markets.”
MIS procedures are being performed across various specialties with GI endoscopes, laparoscopes, arthroscopes, urology endoscopes, gynaecology endoscopes, neuroendoscopes and pulmonary endoscopes, all being widely used. Of these, neuroendoscopes are the fastest growing segment.
MIS have been performed for many years and the acceptance of these procedures has been encouraging. However, inadequate training for operating theatre staff and surgeons is reducing the speed and efficacy of these surgical procedures, thereby hindering market expansion.
“Price is one of the major competitive factors in the European endoscopes market and low-cost equipment manufacturers are taking advantage of this scenario,” adds Jasper. “They are cannibalising revenues, while hampering market growth.”
Low-cost equipment manufacturers offer endoscopes at competitive prices compared to original equipment manufacturers (OEMs). Despite being of relatively lower quality, such devices are making considerable revenue gains due their low price. This has affected the revenues and profitability of OEMs, compelling them to reduce their manufacturing costs in order to sustain market share.
The use of reusable and reposable devices is also creating a challenge for market participants. Hospital authorities support the use of reusable or reposable devices as a cost containment measure, thereby dampening the revenues of disposable device manufacturers.
“MIS are being performed across various specialties; however, there is still scope for their expansion,” states Jasper. “Companies can focus on increasing their application within specialties or in new areas where these surgical procedures have not yet been performed.”
Besides, product bundling will help companies make significant market share gains. Another strategy would be to form alliances across segments, resulting in augmented orders and market share.
“Product line development also plays a pivotal role in winning hospital purchase orders,” concludes Jasper. “For instance, to gain market share in Germany, where the DRG system focuses on purchasing products from a single source, manufacturers should focus on providing an extensive product range.”
European Markets for Minimally Invasive Surgical Devices is part of the Medical Devices Growth Partnership Services, which also includes research in the following markets: European Markets for Guide wires in angiography and angioplasty, European Markets for Peripheral Stents and European Markets for Image Guided Surgeries and Surgical Navigation. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews with the press are available.
About Frost & Sullivan
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics.